abstract |
The present disclosure is generally a method and / or composition for treating mammographic breast density and / or breast hardness in a patient in need thereof, such as a premenopausal, peri-menopausal, or post-menopausal patient, The method and / or composition is directed to administration of an effective amount of an androgen agent and an effective amount of an aromatase inhibitor. The present disclosure is also directed to methods and / or compositions for reducing breast pain. The present disclosure is also directed to methods and / or compositions that reduce elasticity and / or reduce mechanotransduction on the genome of breast cells. The present disclosure is also directed to methods and / or compositions for stabilizing and / or increasing androgen receptor expression levels in breast tissue. [Selection] Figure 1 |